Exam 3 Vocab Flashcards
Chapters 4, 5, 11
Direct Agonist
increases neurotransmitter effect by binding to binding site (mimics neurotransmitter)
Indirect Agonist
increases neurotransmitter effect by binding to alternative binding site
Direct Antagonist
decreases neurotransmitter effect by binding to binding site (blocks neurotransmitter)
Indirect Antagonist
decreases neurotransmitter effect by binding to alternative binding site
Route of Administration
how drug enters body (oral, injection, smoking, etc.)
Intracerebral Administration
drug is administered directly into brain
Intracerebroventricular Administration
drug injected into little ball placed in brain, connected to ventricles via tube
Intrathecal Administration
inject drug into CSF in brain/spine through subarachnoid space
Dose Response Curve
graph of dose vs. specific drug effect, plateaus after a while
Affinity
how well drug ligand binds to receptor
Potency
amount of drug needed to produce response
Effective Dose 50 (ED50)
dose required to get 50% drug effect
Lethal Dose 50 (LD50)
dose that leads to 50% of deaths in test subjects
Therapeutic Index (Margin of Safety)
difference between ED50 and LD50, range of drug dose that’s safe (smaller index = more dangerous)
Tolerance
decrease in drug effectiveness after multiple uses
Opioid Overdose
people who develop opioid tolerance take a break from using drug, when they use the same amount as before they overdose because they no longer have tolerance
Naloxone (Narcan)
opioid receptor antagonist, high affinity, very effective at reversing opioid overdose
Sensitization
increase in drug effectiveness after multiple uses
Acetylcholinesterase
enzyme that destroys acetylcholine
Nicotonic Acetylcholine Receptors
excitatory ionotropic/autonomic, smooth muscle at neuromuscular junctions
Muscarinic Acetylcholine Receptors
metabotropic, parasympathetic nervous system, most common in CNS
Nicotine
ionotropic ACh (nicotinic) agonist, rewarding feeling
Muscarine
metabotropic ACh (muscarinic) agonist, toxic hallucinogenic effect
Atropine
metabotropic ACh (muscarinic) antagonist, block pupil constriction saliva production and block PNS
Curare
ionotropic ACh (nicotinic) antagonist, paralyze muscles
Black Widow Venom
force ACh release from vesicles, force muscle contraction
Choline
used to synthesize ACh, increase ACh in body
Botox
prevent ACh release from vesicles, prevent muscle contraction
Adenosine
purine neurotransmitter, neuronal inhibition, increases during the day to cause sleepiness
Adenosine Receptors
metabotropic receptors
Caffeine
metabotropic adenosine antagonist, prevent feeling sleepy
Glutamate
amino acid neurotransmitter, basic excitatory functions, located throughout brain
AMPA Receptor
glutamate receptor, fast EPSP, ionotropic Na+, made of subunits, everywhere in brain, not effected by one specific drug
NMDA Receptor
glutamate co-receptor with glycine, ionotropic Ca2+ and Na+, turn on via many binding sites, helps change strength of synapses
Excitotoxicity
over-excitation of neurons causes death
Mg2+ Block
voltage gated ion channel of NMDA Receptor
Glycine
co agonist with glutamate at NMDA receptor
Phencyclidine (PCP)
indirect antagonist to glutamate at NMDA receptor, hallucinogen
Ketamine
indirect antagonist to glutamate at NMDA receptor (in large doses), hallucinogen, antidepressant effects (in small doses), possible drug abuse, early anesthesia
Vitamin B6
help create GABA
GABA
amino acid neurotransmitter, basic inhibitory functions, receptors throughout brain
GABAa Receptor
inotropic Cl-
Vitamin B6 Deficiency
less GABA produced, causes seizures and deaths in babies
Benzodiazepines
GABAa agonist, anti-anxiety, muscle relaxant, increase number of Cl- channels opening
Barbiturates
GABAa agonist, anesthesia, epilepsy control, increase Cl- channel open duration